Are health care providers generally unfamiliar with which drugs are available at reduced prices in their health care system?

Loren Bonner

A study published in the October 8, 2024, issue of Neurology revealed the benefits and risks of starting dual antiplatelet therapy (DAPT) with clopidogrel and aspirin within 72 hours of a mild ischemic stroke or transient ischemic attack (TIA).

Aiya Almogaber, PharmD

A NEJM study published in October 2024 found that finerenone may have a role in the treatment of patients with heart failure and mildly reduced or preserved ejection fraction.

Lauren Howell, PharmD

In November 2024, the Journal of the American College of Cardiology published a multisociety guideline on perioperative cardiovascular management for noncardiac surgery (NCS).

Olivia C. Welter, PharmD

Thrombolysis for acute ischemic stroke significantly improves independent recovery when administered within 4.5 hours of symptom onset. The standard thrombolytic agent for many years has been alteplase, but recent research has shown that tenecteplase may have potential benefits over alteplase because it is administered as a single bolus rather than the alteplase regimen of a bolus followed by 1 hour of maintenance infusion.